APA (7th ed.) Citation

Lammer, J., Zeller, T., Hausegger, K. A., Schaefer, P. J., Gschwendtner, M., Mueller-Huelsbeck, S., . . . Schoder, M. (2013). Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: The randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). Journal of the American College of Cardiology (JACC), 62(15), 1320. https://doi.org/10.1016/j.jacc.2013.05.079

Chicago Style (17th ed.) Citation

Lammer, Johannes, et al. "Heparin-bonded Covered Stents Versus Bare-metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis with PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Superficial Femoral Artery Occlusive Disease)." Journal of the American College of Cardiology (JACC) 62, no. 15 (2013): 1320. https://doi.org/10.1016/j.jacc.2013.05.079.

MLA (9th ed.) Citation

Lammer, Johannes, et al. "Heparin-bonded Covered Stents Versus Bare-metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis with PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Superficial Femoral Artery Occlusive Disease)." Journal of the American College of Cardiology (JACC), vol. 62, no. 15, 2013, p. 1320, https://doi.org/10.1016/j.jacc.2013.05.079.